AIMP2通过招募SMURF2来限制EV71的复制,以促进3D聚合酶的降解
Junrui Ren1, Lei Yu2, Qiuhan Zhang2
1State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China.
Virologica Sinica
|June 30, 2024
概括
研究人员发现,AIMP2蛋白通过降解其3D聚合酶来抑制肠道病毒71 (EV71) 感染. 这一发现为开发抗病毒疗法治疗手足口病 (HFMD) 提供了新的策略.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 手足口病 (HFMD),主要是由肠道病毒71 (EV71) 引起的,是亚太地区的重大公共卫生问题,特别是在幼儿中.
- 了解EV71感染机制和病原性对于开发有效的治疗方法至关重要.
- 病毒3D聚合酶 (RNA依赖RNA聚合酶) 对于EV71复制至关重要,也是抗病毒药物开发的关键标.
研究的目的:
- 为了确定参与EV71复制和感染的新型宿主因素.
- 阐明宿主蛋白调节EV71复制的机制.
- 探索对抗肠道病毒感染的潜在新疗法策略.
主要方法:
- 蛋白与蛋白相互作用测试以确定结合EV71 3D聚合酶的宿主因子.
- 乌比基化试验用于确定宿主因子在3D聚合酶降解中的作用.
- 病毒复制试验和针对多种肠道病毒血清型的抗病毒疗效测试.
主要成果:
- 一种新的宿主蛋白,AIMP2,被确定可以结合和抑制EV71 3D聚合酶.
- AIMP2招募了E3结合酶SMURF2,导致3D聚合酶的聚基化和随后的降解.
- AIMP2对EV71,CVA16和CVB1血清型表现出抗病毒活性.
结论:
- 通过针对性降解病毒3D聚合酶,AIMP2作为对EV71感染的宿主限制因子.
- 这项研究揭示了一种新的抗病毒机制,涉及AIMP2介导的肠道病毒复制的调节.
- 这些发现为开发针对宿主-病原体相互作用的抗肠道病毒疗法提供了新的途径.
更多相关视频
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
17.4K
10:22Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
8.7K
相关概念视频
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Nonsense-mediated mRNA Decay
10.6K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.6K
RNA Polymerase II Accessory Proteins
9.2K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.2K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
